Abstract
The nonprotein amino acid taurine has been shown to counteract the negative effects of a high-fructose diet in rats with regard to insulin resistance and dyslipidemia. Here we examined the long-term (26 weeks) effects of oral taurine supplementation (2% in the drinking water) in fructose-fed Wistar rats.
The combination of fructose and taurine caused a significant increase in fasting glucose compared to the control diet without changing hepatic phosphoenol pyruvate carboxykinase mRNA levels. The combination of fructose and taurine also improved glucose tolerance compared to control. Neither a high-fructose diet nor taurine supplementation induced significant changes in body weight, body fat or total calorie intake, fasting insulin levels, HOMA-IR, or insulin-induced Akt phosphorylation in skeletal muscle.
Fructose alone caused a decrease in liver triglyceride content, with taurine supplementation preventing this. There was no effect of long-term fructose diet and/or taurine supplementation on plasma triglycerides, plasma nonesterified fatty acids, as well as plasma HDL, LDL, and total cholesterol.
In conclusion, the study suggests that long-term taurine supplementation improves glucose tolerance and normalize hepatic triglyceride content following long-term fructose feeding. However, as the combination of taurine and fructose also increased fasting glucose levels, the beneficial effect of taurine supplementation towards amelioration of glucose intolerance and insulin resistance may be questionable.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- Fru:
-
Fructose
- HDL:
-
High-density lipoprotein cholesterol
- HOMA-IR:
-
Homeostasis model assessment of insulin resistance
- LDL:
-
Low-density lipoprotein cholesterol
- OGTT:
-
Oral glucose tolerance test
- Tau:
-
Taurine
References
Abdullah MM, Riediger NN, Chen Q et al (2009) Effects of long-term consumption of a high-fructose diet on conventional cardiovascular risk factors in Sprague–Dawley rats. Mol Cell Biochem 327:247–256. doi:10.1007/s11010-009-0063-z
Abramoff M, Magalhaes P, Ram S (2004) Image Processing with ImageJ. J Biophotonics Int 11:36–42
Ackermann D, Heinsen H (1935) Über die physiologische Wirkung des Asterubins und anderer, zum Teil neu dargestellter schwelfelhaltiger Guanidinderivate. Hoppe Seyles Z Physiol Chemie 235:115–121
Basciano H, Federico L, Adeli K (2005) Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2:5. doi:doi: 10.1186/1743-7075-2-5
Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57–63
Carneiro EM, Latorraca MQ, Araujo E et al (2009) Taurine supplementation modulates glucose homeostasis and islet function. J Nutr Biochem 20:503–511. doi:10.1016/j.jnutbio.2008.05.008
Dokshina GA, Silaeva TI, Lartsev EI (1976) Insulin-like effects of taurine. Vopr Med Khim 22:503–507
El Mesallamy HO, El-Demerdash E, Hammad LN, El Magdoub HM (2010) Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance. Diabetol Metab Syndr 2:46. doi:10.1186/1758-5996-2-46
Elizarova EP, Nedosugova LV (1996) First experiments in taurine administration for diabetes mellitus. The effect on erythrocyte membranes Adv Exp Med Biol 403:583–588
Franconi F, Bennardini F, Mattana A et al (1995) Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 61:1115–1119
Franconi F, Loizzo A, Ghirlanda G, Seghieri G (2006) Taurine supplementation and diabetes mellitus. Curr Opin Clin Nutr Metab Care 9:32–36
Franconi F, Miceli M, Fazzini A et al (1996) Taurine and diabetes. Humans and experimental models Adv Exp Med Biol 403:579–582
Hansen SH (2001) The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 17:330–346
Harada N, Ninomiya C, Osako Y et al (2004) Taurine alters respiratory gas exchange and nutrient metabolism in type 2 diabetic rats. Obes Res 12:1077–1084. doi:10.1038/oby.2004.135
Kates M (1986) Techniques in Lipidology. Elsevier, New York, p 142
Kawano K, Hirashima T, Mori S et al (1992) Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41:1422–1428
Kim JY, Nolte LA, Hansen PA et al (1999) Insulin resistance of muscle glucose transport in male and female rats fed a high-sucrose diet. Am J Physiol 276:R665–R672
Kim S-J, Gupta RC, Lee HW (2007) Taurine-diabetes interaction: from involvement to protection. Curr Diabetes Rev 3:165–175
Kulakowski EC, Maturo J (1984) Hypoglycemic properties of taurine: not mediated by enhanced insulin release. Biochem Pharmacol 33:2835–2838
Lau-Cam CA, Patel JP (2006) Comparison of the effects of taurine with those of related sulfur-containing compounds on pyridoxal-induced adrenomedullary catecholamine release and glycogenolysis in the rat. Adv Exp Med Biol 583:203–212
De Luca G, Calpona PR, Caponetti A et al (2001) Preliminary report: amino acid profile in platelets of diabetic patients. Metab Clin Exp 50:739–741. doi:10.1053/meta.2001.24193
Lustig RH, Schmidt LA, Brindis CD (2012) Public health: the toxic truth about sugar. Nature 482:27–29. doi:10.1038/482027a
Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Nakaya Y, Minami A, Harada N et al (2000) Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr 71:54–58
Nandhini ATA, Anuradha CV (2002) Taurine modulates kallikrein activity and glucose metabolism in insulin resistant rats. Amino Acids 22:27–38
Nandhini ATA, Thirunavukkarasu V, Anuradha CV (2004) Stimulation of glucose utilization and inhibition of protein glycation and AGE products by taurine. Acta Physiol Scand 181:297–303. doi:10.1111/j.1365-201X.2004.01287.x
Nandhini ATA, Thirunavukkarasu V, Anuradha CV (2005) Taurine modifies insulin signaling enzymes in the fructose-fed insulin resistant rats. Diabetes Metab 31:337–344
Nardelli TR, Ribeiro RA, Balbo SL et al (2011) Taurine prevents fat deposition and ameliorates plasma lipid profile in monosodium glutamate-obese rats. Amino Acids 41:901–908. doi:10.1007/s00726-010-0789-7
Nishimura N, Umeda C, Ona H, Yokogoshi H (2002) The effect of taurine on plasma cholesterol concentration in genetic type 2 diabetic GK rats. J Nutr Sci Vitaminol 48:483–490
Patel JP, Lau-Cam CA (2006) Taurine attenuates pyridoxal-induced adrenomedullary catecholamine release and glycogenolysis in the rat. Adv Exp Med Biol 583:147–156
Perret P, Slimani L, Briat A et al (2007) Assessment of insulin resistance in fructose-fed rats with 125I-6-deoxy-6-iodo-D-glucose, a new tracer of glucose transport. Eur J Nucl Med Mol Imaging 34:734–744. doi:10.1007/s00259-006-0267-3
Pilkis SJ, Granner DK (1992) Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 54:885–909. doi:10.1146/annurev.ph.54.030192.004321
Samuel VT (2011) Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metab 22:60–65. doi:10.1016/j.tem.2010.10.003
Seshasai SRK, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841. doi:10.1056/NEJMoa1008862
Singh S, Dhingra S, Ramdath DD et al (2010) Risk factors preceding type 2 diabetes and cardiomyopathy. J Cardiovasc Transl Res 3:580–596. doi:10.1007/s12265-010-9197-3
Stanhope KL (2012) Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome. Annu Rev Med 63:329–343. doi:10.1146/annurev-med-042010-113026
Stark AH, Timar B, Madar Z (2000) Adaptation of Sprague Dawley rats to long-term feeding of high fat or high fructose diets. Eur J Nutr 39:229–234
Tappy L, Lê K-A (2010) Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 90:23–46. doi:10.1152/physrev.00019.2009
Tappy L, Lê KA, Tran C, Paquot N (2010) Fructose and metabolic diseases: new findings, new questions. Nutrition 26:1044–1049. doi:10.1016/j.nut.2010.02.014
Wieland O (1984) Methods of enzymatic analysis vol. VI. Verlag Chemie, Weinheim, pp 504–510
Yan CC, Bravo E, Cantàfora A (1993) Effect of taurine levels on liver lipid metabolism: an in vivo study in the rat. Proc Soc Exp Biol Med 202:88–96
Acknowledgements
This research was supported by The Danish Strategic Research Council grant #09-067124 and #09-059921, Danish Medical Research Council grant #271-07-0732, by Købmand i Odense Johann og Hanne Weimann f. Seedorffs Legat, Gangstedfonden, Ernst Fischers mindelegat, Eva og Hans Carl Adolfs Mindelegat, and Direktør Emil Hertz og Hustru Inger Hertz Fond.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this paper
Cite this paper
Larsen, L.H., Ørstrup, L.K.H., Hansen, S.H., Grunnet, N., Quistorff, B., Mortensen, O.H. (2013). The Effect of Long-Term Taurine Supplementation and Fructose Feeding on Glucose and Lipid Homeostasis in Wistar Rats. In: El Idrissi, A., L'Amoreaux, W. (eds) Taurine 8. Advances in Experimental Medicine and Biology, vol 776. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6093-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6093-0_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6092-3
Online ISBN: 978-1-4614-6093-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)